Author

Greta Lorenzon

RISK OF COVID-19 IN CELIAC DISEASE PATIENTS
RISK OF COVID-19 IN CELIAC DISEASE PATIENTS

Greta Lorenzon  et al.

COMPARATIVE ASSESSMENT C-REACTIVE PROTEIN BETWEEN A POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (IMMUNONEPHELOMETRIC TESTING)
COMPARATIVE ASSESSMENT C-REACTIVE PROTEIN BETWEEN A POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (IMMUNONEPHELOMETRIC TESTING)

COMPARATIVE ASSESSMENT C-REACTIVE PROTEIN BETWEEN A POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (IMMUNONEPHELOMETRIC TESTING)
COMPARATIVE ASSESSMENT C-REACTIVE PROTEIN BETWEEN A POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (IMMUNONEPHELOMETRIC TESTING)

Greta Lorenzon  et al.

COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Greta Lorenzon  et al.

BIOLOGIC AGENTS IN IBD PATIENTS AFTER SOLID ORGAN TRANSPLANTATION DO NOT INCREASE THE RATES OF INFECTION OR ADVERSE EVENTS
BIOLOGIC AGENTS IN IBD PATIENTS AFTER SOLID ORGAN TRANSPLANTATION DO NOT INCREASE THE RATES OF INFECTION OR ADVERSE EVENTS

Greta Lorenzon  et al.

COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Greta Lorenzon  et al.

NUTRITIONAL STATUS ASSESSMENT IN COELIAC DISEASE
NUTRITIONAL STATUS ASSESSMENT IN COELIAC DISEASE

Greta Lorenzon  et al.

IDENTIFICATION OF MARKERS OF OXIDATIVE STRESS IN CELIAC DISEASE
IDENTIFICATION OF MARKERS OF OXIDATIVE STRESS IN CELIAC DISEASE

Greta Lorenzon  et al.

NUTRITIONAL STATUS AND BODY COMPOSITION ASSESSMENT IN CELIAC DISEASE
NUTRITIONAL STATUS AND BODY COMPOSITION ASSESSMENT IN CELIAC DISEASE

Greta Lorenzon  et al.

NEGATIVE IMPACT OF INFLAMMATORY BOWEL DISEASE ON WOMEN’S REPRODUCTIVE LIFE: A SURVEY-BASED CONTROLLED STUDY
NEGATIVE IMPACT OF INFLAMMATORY BOWEL DISEASE ON WOMEN’S REPRODUCTIVE LIFE: A SURVEY-BASED CONTROLLED STUDY

Greta Lorenzon  et al.

DUODENAL HISTOLOGICAL FINDINGS AND RISK OF CELIAC DISEASE IN SUBJECTS WITH AUTOIMMUNE ATROPHIC GASTRITIS: A RETROSPECTIVE EVALUATION
DUODENAL HISTOLOGICAL FINDINGS AND RISK OF CELIAC DISEASE IN SUBJECTS WITH AUTOIMMUNE ATROPHIC GASTRITIS: A RETROSPECTIVE EVALUATION

Greta Lorenzon  et al.

SWITCHING FROM ADALIMUMAB ORIGINATOR TO ABP 501 BIOSIMILAR: A MULTICENTRIC NORTH ITALIAN STUDY
SWITCHING FROM ADALIMUMAB ORIGINATOR TO ABP 501 BIOSIMILAR: A MULTICENTRIC NORTH ITALIAN STUDY

Greta Lorenzon  et al.

THE ANTI IL-23/IL-12 AGENT USTEKINUMAB IS AN EFFECTIVE AND SAFE INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE REFRACTORY OR INTOLERANT TO ANTI-TNF: A MULTICENTRE ITALIAN STUDY
THE ANTI IL-23/IL-12 AGENT USTEKINUMAB IS AN EFFECTIVE AND SAFE INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE REFRACTORY OR INTOLERANT TO ANTI-TNF: A MULTICENTRE ITALIAN STUDY

Greta Lorenzon  et al.

DISEASE COURSE OF CROHN’S DISEASE DURING THE FIRST TEN YEARS FOLLOWING DIAGNOSIS IN A PROSPECTIVE EUROPEAN POPULATION-BASED INCEPTION COHORT – THE EPI-IBD COHORT
DISEASE COURSE OF CROHN’S DISEASE DURING THE FIRST TEN YEARS FOLLOWING DIAGNOSIS IN A PROSPECTIVE EUROPEAN POPULATION-BASED INCEPTION COHORT – THE EPI-IBD COHORT

Greta Lorenzon  et al.

DISEASE COURSE OF ULCERATIVE COLITIS DURING THE FIRST TEN YEARS FOLLOWING DIAGNOSIS IN A PROSPECTIVE EUROPEAN POPULATION-BASED INCEPTION COHORT – THE EPI-IBD COHORT
DISEASE COURSE OF ULCERATIVE COLITIS DURING THE FIRST TEN YEARS FOLLOWING DIAGNOSIS IN A PROSPECTIVE EUROPEAN POPULATION-BASED INCEPTION COHORT – THE EPI-IBD COHORT

Greta Lorenzon  et al.

THE ROAD TO AND SEQUENCE OF BIOLOGICAL THERAPY IN A POPULATION-BASED, EUROPEAN INCEPTION COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE -AN EPI-IBD COHORT STUDY
THE ROAD TO AND SEQUENCE OF BIOLOGICAL THERAPY IN A POPULATION-BASED, EUROPEAN INCEPTION COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE -AN EPI-IBD COHORT STUDY

Greta Lorenzon  et al.

Item 1 - 16 / 16
1